Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Trigueros Motos, Laia ^a,b   Pérez Torras, Sandra ^a   Casado, F J ^a   Molina Arcas, Míriam ^a,c   Pastor Anglada, Marçal ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 3; CISPLATIN; DOXIFLURIDINE; FAS ANTIGEN; FLUOROURACIL; GEMCITABINE; MESSENGER RNA; NUCLEOSIDE DERIVATIVE; PROTEIN P21; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL STRAIN HT29; CELL STRAIN MCF 7; CELL VOLUME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; GENOTOXICITY; HUMAN; HUMAN CELL; INCUBATION TIME; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; AQUAPORIN 3; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SIZE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOXURIDINE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MCF-7 CELLS; NUCLEOSIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UP-REGULATION;

EID: 84866676119     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-434     Document Type: Article

References (36)

1. Hernandez-Vargas H, Rodriguez-Pinilla SM, Julian-Tendero M, Sanchez-Rovira P, Cuevas C, Anton A, Rios MJ, Palacios J, Moreno-Bueno G. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat 2007, 102(2):157-172. 10.1007/s10549-006-9322-9, 17039268.
2. Lopez-Guerra M, Trigueros-Motos L, Molina-Arcas M, Villamor N, Casado FJ, Montserrat E, Campo E, Colomer D, Pastor-Anglada M. Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells. Haematologica 2008, 93(12):1843-1851. 10.3324/haematol.13186, 18945750.
3. Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem 2004, 279(20):21183-21192. 10.1074/jbc.M311912200, 15016801.
4. Molina-Arcas M, Moreno-Bueno G, Cano-Soldado P, Hernandez-Vargas H, Casado FJ, Palacios J, Pastor-Anglada M. Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells. Biochem Pharmacol 2006, 72(12):1646-1656. 10.1016/j.bcp.2006.07.036, 16965766.
5. Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, Engel A, Nielsen S. Aquaporin water channels-from atomic structure to clinical medicine. J Physiol 2002, 542(Pt 1):3-16. 2290382, 12096044.
6. Verkman AS. Aquaporins: translating bench research to human disease. J Exp Biol 2009, 212(Pt 11):1707-1715. 2683014, 19448080.
7. Ishibashi K, Kondo S, Hara S, Morishita Y. The evolutionary aspects of aquaporin family. Am J Physiol Regul Integr Comp Physiol 2011, 300(3):R566-R576. 10.1152/ajpregu.90464.2008, 21148473.
8. Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins-new players in cancer biology. J Mol Med 2008, 86(5):523-529. 10.1007/s00109-008-0303-9, 18311471.
9. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005, 434(7034):786-792. 10.1038/nature03460, 15815633.
10. Hu J, Verkman AS. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J 2006, 20(11):1892-1894. 10.1096/fj.06-5930fje, 16818469.
11. Hara-Chikuma M, Verkman AS. Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol Cell Biol 2008, 28(1):326-332. 10.1128/MCB.01482-07, 2223314, 17967887.
12. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB, Benos DJ. Differential gene expression profiling in human brain tumors. Physiol Genomics 2001, 5(1):21-33.
13. Moon C, Soria JC, Jang SJ, Lee J, Obaidul Hoque M, Sibony M, Trink B, Chang YS, Sidransky D, Mao L. Involvement of aquaporins in colorectal carcinogenesis. Oncogene 2003, 22(43):6699-6703. 10.1038/sj.onc.1206762, 14555983.
14. Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother 2010, 64(5):313-318. 10.1016/j.biopha.2009.12.003, 20106632.
15. Melis M, Hernandez J, Siegel EM, McLoughlin JM, Ly QP, Nair RM, Lewis JM, Jensen EH, Alvarado MD, Coppola D, et al. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum 2010, 53(6):936-943. 10.1007/DCR.0b013e3181d320c4, 20485009.
16. Villanueva A, Garcia C, Paules AB, Vicente M, Megias M, Reyes G, de Villalonga P, Agell N, Lluis F, Bachs O, et al. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 1998, 17(15):1969-1978. 10.1038/sj.onc.1202118, 9788440.
17. Cano-Soldado P, Molina-Arcas M, Alguero B, Larrayoz I, Lostao MP, Grandas A, Casado FJ, Pastor-Anglada M. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells. Biochem Pharmacol 2008, 75(3):639-648. 10.1016/j.bcp.2007.10.005, 18053967.
18. Zelenina M, Tritto S, Bondar AA, Zelenin S, Aperia A. Copper inhibits the water and glycerol permeability of aquaporin-3. J Biol Chem 2004, 279(50):51939-51943. 10.1074/jbc.M407645200, 15456785.
19. Ji C, Cao C, Lu S, Kivlin R, Amaral A, Kouttab N, Yang H, Chu W, Bi Z, Di W, et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 2008, 62(5):857-865. 10.1007/s00280-007-0674-6, 18214481.
20. Kawamoto K. Flow cytometric analysis of cell cycle for the action mechanism of antineoplastic agents. Hum Cell 1995, 8(3):85-88.
21. Mobasheri A, Wray S, Marples D. Distribution of AQP2 and AQP3 water channels in human tissue microarrays. J Mol Histol 2005, 36(1-2):1-14.
22. Kwon TH, Nielsen J, Masilamani S, Hager H, Knepper MA, Frokiaer J, Nielsen S. Regulation of collecting duct AQP3 expression: response to mineralocorticoid. Am J Physiol Renal Physiol 2002, 283(6):F1403-F1421.
23. Matsuzaki T, Suzuki T, Takata K. Hypertonicity-induced expression of aquaporin 3 in MDCK cells. Am J Physiol Cell Physiol 2001, 281(1):C55-C63.
24. Nakakoshi M, Morishita Y, Usui K, Ohtsuki M, Ishibashi K. Identification of a keratinocarcinoma cell line expressing AQP3. Biol Cell 2006, 98(2):95-100. 10.1042/BC20040127, 15898954.
25. Delporte C, Chen ZJ, Baum BJ. Aquaporin 1 expression during the cell cycle in A5 cells. Biochem Biophys Res Commun 1996, 228(2):223-228. 10.1006/bbrc.1996.1645, 8920898.
26. Hara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc Natl Acad Sci U S A 2003, 100(12):7360-7365. 10.1073/pnas.1230416100, 165880, 12771381.
27. Hara-Chikuma M, Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med 2008, 86(2):221-231. 10.1007/s00109-007-0272-4, 17968524.
28. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med 1995, 1(5):417-422. 10.1038/nm0595-417, 7585087.
29. Petit F, Fromenty B, Owen A, Estaquier J. Mitochondria are sensors for HIV drugs. Trends Pharmacol Sci 2005, 26(5):258-264. 10.1016/j.tips.2005.03.006, 15860373.
30. Yeo TK, Kintner J, Armand R, Perez R, Lewis LD. Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells. Hum Exp Toxicol 2007, 26(12):911-921. 10.1177/0960327107086513, 18375634.
31. Fowler JD, Brown JA, Johnson KA, Suo Z. Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase. J Biol Chem 2008, 283(22):15339-15348. 10.1074/jbc.M800310200, 2397453,2397453, 18378680.
32. Pastor-Anglada M, Felipe A, Casado FJ. Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends Pharmacol Sci 1998, 19(10):424-430. 10.1016/S0165-6147(98)01253-X, 9803833.
33. Pastor-Anglada MC FJ. Nucleoside transport into cells: role of nucleoside transporters SLC28 and SLC29 in cancer chemotherapy. Deoxynucleoside Analogs in Cancer Therapy Totowa 2007, New Jersey: Humana Press.
34. Zheng X, Chen X. Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. FEBS Lett 2001, 489(1):4-7. 10.1016/S0014-5793(00)02437-6, 11231003.
35. Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X, et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 2008, 32(6):803-814. 10.1016/j.molcel.2008.11.019, 19111660.
36. Woo J, Lee J, Chae YK, Kim MS, Baek JH, Park JC, Park MJ, Smith IM, Trink B, Ratovitski E, et al. Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation. Cancer Lett 2008, 264(1):54-62. 10.1016/j.canlet.2008.01.029, 3074481, 18423983.